DOI: https://doi.org/10.24026/1818-1384.2(23).2008.118412

Віддалені результати хірургічного лікування раку щитоподібної залози

О. С. Ларін

Анотація


In the article the 5 and 10 years results of surgical treatment of 1366 (76%) from 1797 primary cases of thyroid cancer have been analyzed. All patients were operated within 1996-2006 years in Ukrainian scientific and practical center of endocrine surgery. Indices of survival, cancer specific mortality, rate of relapses and distant metastases were calculated separately for each morphologic form of thyroid carcinoma and for each clinical stage of patients. Despite good overall 10 years survival (92%) contributed by favorable out comes of the most common papillary and follicular thyroid carcinoma, corresponding indices for less common (4% of all cases) medullary carcinoma are much worser (80% and 67% at 5 and 10 years after operation). Poor differentiated and particularly undifferentiated (anaplastic) thyroid cancer demonstrated extremely unfavorable prognosis with no survival beyond 1 year after operation for anaplastic tumor. These both morphologic forms comprise 1.5% of all cases of thyroid cancer whereas papillary and follicular carcinomas comprise 85% and 9% correspondingly.

Ключові слова


thyroid cancer; surgery; long-term outcomes

Повний текст:

PDF

Посилання


Mazzaferri E.L., Kloos R.T. Current approaches to primary therapy for papillary and follicular thyroid cancer // J. Clin. Endocrinol. Metabolism. — 2001. — Vol.86, No4. — P 1447-1463.

Hay I.D., Bergstralh E.J., Goellner J.R., et al. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1,779 patients surgically treated at one institution during 1940 through 1989 // Surgery. — 1993. — Vol.114. — Р. 1050-1058.

Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base Report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985 1995 // Cancer. — 1998. — Р. 2638-48.

Cupisti K., Wolf A., Raffel A. et al. Long term clinical and biochemical follow up in medullary thyroid carcinoma: a single institution's experience over 20 years. // Ann Surg. — 2007. — Vol. 246, No5. — Р. 815-821.

Sanders Jr.E.M., LiVolsi V.A., Brierley J., Shin J., Randolph G. W. An evidence based review of poorly differentiated thyroid cancer // World J Surg. — 2007. — Vol.31. — Р. 934-945.

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer (The ATA Guidelines taskforce: Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., Mazzaferri E.L., McIver B., Sherman S.I., Tuttle R.M.) // Thyroid. — 2006. — Vol. 16, No2.

European consensus for the management of patients with differentiated thyroid cancer of the follicular epithelium (Pacini F., Schlumberger M., Dralle H., Elisei R., Wiersinga W. and the European Thyroid Cancer Taskforce) // European J Endocrinology. — 2006. — Vol.154, Issue 6. — P. 787-803.

Shaha А.: TNM Classification of Thyroid Carcinoma // World J Surg. — 2007. — Vol.31. — Р. 879-887.

Sherman S.I. The management of metastatic differentiated thyroid carcinoma // Reviews in Endocrine and Metabolic Disorders. — 2000. — V.1, No3. — P. 165 171.

Гульчій М.В. Сучасні тенденції формування раку щитоподібної залози у населення України та ефективність його лікування // Вісник наукових досліджень. — 2005. — No1. — С. 161-165.

Горбенко В.Н., Гулак Л.О., Федоренко З.П., Винник Ю.А. Рак щитовидной железы в Украине (1989-2004 гг.) // Международный эндокринологический журнал. — 2007. — No2(8). — С.34-38.

International Union Against Cancer (UICC): TNM Classification of malignant tumours. 6-th ed Sobin LH, Wittekind Ch., eds. NY: Wiley; 2002.


Пристатейна бібліографія ГОСТ








Creative Commons License
Ця робота ліцензована Creative Commons Attribution-NonCommercial 4.0 International License.

© Клінічна ендокринологія та ендокринна хірургія.

ISSN: 1818-1384 (Print), e-ISSN: 2519-2582, DOI: 10.24026/1818-1384.

При копіюванні активне посилання на матеріал обов'язкове.

Flag Counter